Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKinovo Plc Regulatory News (KINO)

Share Price Information for Kinovo Plc (KINO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.00
Bid: 40.00
Ask: 42.00
Change: -0.40 (-0.97%)
Spread: 2.00 (5.00%)
Open: 41.00
High: 41.00
Low: 41.00
Prev. Close: 41.40
KINO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement regarding possible offer

1 Sep 2023 11:00

RNS Number : 1358L
Kinovo PLC
01 September 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.4 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE") AND DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CODE. THERE CAN BE NO CERTAINTY THAT ANY FIRM OFFER WILL BE MADE NOR AS TO THE TERMS ON WHICH ANY FIRM OFFER MIGHT BE MADE.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

For immediate release

1st September 2023

Kinovo plc ("Kinovo" or the "Company")

Statement regarding possible offer

On 24 August 2023, Kinovo announced that it had received a non-binding indicative offer from Rx3 Holdings Limited ("Rx3") which may or may not lead to an offer being made by Rx3 for the entire issued and to be issued share capital of Kinovo at a price of 56 pence per share, payable in cash (the "Possible Offer"). Rx3 and Tipacs2 Limited ("Tipacs2") are both ultimately owned by Mr Tim Scott.

The Directors have concluded that if the Possible Offer of 56 pence per share was made by Rx3 they will not be recommending it to shareholders. The Directors have undertaken a process of consultation with certain key shareholders and considered direct shareholder feedback in reaching this conclusion. 

 

Shareholders are urged to take no action at this time.

This announcement has been made by Kinovo without the approval of Rx3.

In accordance with Rule 2.6(a) of the Code, Rx3 must, by no later than 5.00 p.m. (London time) on 21 September 2023, either announce a firm intention to make an offer for Kinovo in accordance with Rule 2.7 of the Code, or announce that it does not intend to make an offer, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. The deadline can be extended with the consent of the Takeover Panel in accordance with Rule 2.6(c) of the Code.

Enquiries

Kinovo plc

Sangita Shah, Chair

David Bullen, Chief Executive Officer

 

+44 (0)20 7796 4133

(via Hudson Sandler)

 

Canaccord Genuity Limited (Financial Adviser, Nominated Adviser and Broker)

+44 (0)20 7523 8000

Bobbie Hilliam

Adam James

Andrew Potts

Harry Rees

Hudson Sandler (Financial PR)

+44 (0) 20 7796 4133

Dan de Belder

Harry Griffiths

Canaccord Genuity Limited, which is authorised and regulated in the United Kingdom by the FCA, is acting as financial adviser and corporate broker exclusively for Kinovo and for no one else in connection with the Possible Offer and will not regard any other person as its client in relation to the matters referred to in this announcement and will not be responsible to anyone other than Kinovo for providing the protections afforded to clients of Canaccord Genuity Limited, nor for providing advice in relation to the Possible Offer or any other matter referred to in this announcement.

The person responsible for arranging the release of this announcement on behalf of Kinovo plc is Sangita Shah.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse (Amendment) (EU Exit) Regulations 2019. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OFDKFLBBXKLZBBL
Date   Source Headline
25th Mar 20244:36 pmRNSExercise of Options, PDMR Shareholdings & TVR
11th Mar 20247:00 amRNSDirector/PDMR Shareholding
8th Mar 20247:00 amRNSUpdate on DCB Discontinued Operations
9th Feb 20247:00 amRNSTrading Update
28th Nov 20237:00 amRNSInterim Results
22nd Nov 20237:00 amRNSNotice of Investor Presentation
7th Nov 20237:00 amRNSFirst Half Trading Update
26th Sep 20232:30 pmRNSDirector/PDMR Shareholdings
25th Sep 20237:00 amRNSDirector/PDMR Shareholding
20th Sep 20237:00 amRNSStatement regarding Rule 2.8 announcement
19th Sep 202312:53 pmRNSNo intention to bid statement
19th Sep 202311:30 amRNSForm 8.5 (EPT/RI) - Kinovo PLC
15th Sep 202311:43 amRNSForm 8.5 (EPT/RI)
13th Sep 20233:30 pmRNSForm 8.3 - Kinovo plc - Neil Rooney
13th Sep 20233:30 pmRNSForm 8.3 - Kinovo plc - JTC Employer Solutions
13th Sep 20237:00 amRNSDecarbonisation Direct Award
12th Sep 20236:03 pmRNSForm 8.3 - KINOVO PLC
12th Sep 20233:23 pmRNSForm 8.3 - KINOVO PLC
12th Sep 20239:20 amRNSForm 8.5 (EPT/RI)
8th Sep 20234:30 pmRNSForm 8.3 - Kinovo plc - Fiduchi Trustees Ltd
8th Sep 202311:45 amRNSForm 8 (OPD) - Kinovo plc
8th Sep 20239:55 amRNSForm 8.3 - Kinovo Plc
7th Sep 20236:25 pmRNSForm 8.3 - Kinovo plc
7th Sep 202310:29 amRNSForm 8.3 - Kinovo plc - Amendment
7th Sep 20237:00 amRNSAdditional Framework Wins and Direct Award
5th Sep 20233:30 pmRNSForm 8.3 - Kinovo plc - Michael Whitaker
5th Sep 202311:15 amRNSForm 8.3 - Kinovo plc
5th Sep 20238:34 amRNSForm 8.5 (EPT/RI)
5th Sep 20237:00 amRNSRenewal of Bank Facilities
4th Sep 202311:10 amRNSForm 8.5 (EPT/RI) - Kinovo PLC
1st Sep 202312:51 pmRNSForm 8.3 - KINOVO PLC
1st Sep 202312:37 pmRNSForm 8 (OPD) (Rx3 Holdings Limited)
1st Sep 202311:00 amRNSStatement regarding possible offer
1st Sep 202310:26 amRNSForm 8.5 (EPT/RI)
31st Aug 20236:29 pmRNSTotal Voting Rights
31st Aug 20236:29 pmRNSForm 8.3 - Kinovo plc
31st Aug 20234:55 pmRNSForm 8.3 - Kinovo PLC
31st Aug 20239:53 amRNSForm 8.5 (EPT/RI)
31st Aug 20237:00 amRNSResult of AGM
30th Aug 202310:00 amRNSForm 8.5 (EPT/RI)
30th Aug 20237:00 amRNSPossible offer for Kinovo plc
29th Aug 20232:27 pmRNSForm 8.3 - Kinovo PLC
29th Aug 202310:31 amRNSForm 8.3 - KINOVO PLC
29th Aug 202310:08 amRNSForm 8.5 (EPT/RI) - Kinovo PLC
25th Aug 20233:24 pmRNSForm 8.3 - Kinovo plc
25th Aug 202312:06 pmRNSForm 8.3 - Kinovo PLC
25th Aug 202311:54 amPRNForm 8.3 - Kinovo Plc
25th Aug 20239:10 amRNSForm 8.5 (EPT/RI)
25th Aug 20237:00 amRNSRule 2.9 announcement
25th Aug 20237:00 amRNSShare Incentive Plan, Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.